ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 256 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,574,032 | -52.4% | 60,563 | -47.6% | 0.01% | -52.2% |
| Q1 2024 | $3,303,443 | +89.4% | 115,505 | +102.7% | 0.02% | +76.9% |
| Q4 2023 | $1,743,955 | +60.0% | 56,992 | +40.5% | 0.01% | +44.4% |
| Q3 2023 | $1,089,820 | -23.2% | 40,559 | +2.0% | 0.01% | -18.2% |
| Q2 2023 | $1,418,234 | +18.9% | 39,771 | -15.3% | 0.01% | +10.0% |
| Q1 2023 | $1,193,114 | -37.5% | 46,973 | -0.3% | 0.01% | -41.2% |
| Q4 2022 | $1,910,498 | +20.0% | 47,103 | -2.2% | 0.02% | +13.3% |
| Q3 2022 | $1,592,000 | -20.3% | 48,161 | -15.2% | 0.02% | -6.2% |
| Q2 2022 | $1,998,000 | -23.8% | 56,763 | -0.5% | 0.02% | 0.0% |
| Q1 2022 | $2,623,000 | -22.0% | 57,036 | +12.4% | 0.02% | -11.1% |
| Q4 2021 | $3,363,000 | +2.8% | 50,729 | -3.1% | 0.02% | -10.0% |
| Q3 2021 | $3,270,000 | -18.5% | 52,373 | +8.2% | 0.02% | -16.7% |
| Q2 2021 | $4,010,000 | +12.5% | 48,421 | -9.9% | 0.02% | +4.3% |
| Q1 2021 | $3,565,000 | -9.4% | 53,765 | +4.8% | 0.02% | -8.0% |
| Q4 2020 | $3,937,000 | +2.3% | 51,313 | -42.6% | 0.02% | -10.7% |
| Q3 2020 | $3,850,000 | -15.0% | 89,421 | -14.7% | 0.03% | -20.0% |
| Q2 2020 | $4,530,000 | +110.0% | 104,886 | +39.9% | 0.04% | +59.1% |
| Q1 2020 | $2,157,000 | -59.1% | 74,972 | -9.8% | 0.02% | -45.0% |
| Q4 2019 | $5,274,000 | +2035.2% | 83,154 | +847.3% | 0.04% | +1900.0% |
| Q3 2019 | $247,000 | +13.3% | 8,778 | +6.9% | 0.00% | 0.0% |
| Q2 2019 | $218,000 | – | 8,212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
| Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
| Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
| ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
| Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
| Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
| Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
| Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
| OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |